Two inactivated vaccines from China’s Sinopharm successfully suppressed Covid-19, according to Bloomberg. The findings, published by a U.S medical journal, found the shots to be 72.8% and 78.1% effective against symptomatic infections.
The study, published by the American Medical Association journal, confirmed earlier claims by Sinopharm of its vaccine effectiveness.
Chinese vaccine makers have faced criticisms for not giving sufficient information about their safety and efficacy.
Cases rose in countries that used Chinese shots heightening doubts about their effectiveness.
Lack of information on the vaccines developed by China’s drug makers delayed their approval by WHO and other regulators.
Earlier in the month, WHO approved one of the two vaccines from Sinopharm, allowing worldwide distribution.
Sinopharm stock is currently declining, 1099: HKG is down 2.45%
